Clinical Trials
A New Era of Cellular Therapy and Cancer Care
A new state-of-the-art inpatient cellular therapy unit bridges discovery and delivery of the most advanced care.
New Fluorescence-Guided Surgery Clinical Trial Opens to Patients with Glioblastoma
In this video Q&A, neurosurgeon Linton T. Evans, MD, talks about his new clinical trial to improve surgical outcomes for patients with newly diagnosed glioblastoma brain tumors.
Enhancing Community Access to Cancer Clinical Trials and Care
Patients in New Hampshire, Vermont, and throughout New England are gaining greater access to promising cancer treatments and clinical trials without having to travel far from home.
New Study Finds Common Blood Pressure Drug Boosts Cancer Treatment
Dartmouth Cancer Center researchers find that the common blood pressure medication telmisartan can significantly boost the cancer drug olaparib.
Personalizing Chemotherapy Dosing for GI Cancers
A Dartmouth Cancer Center clinical trial is exploring a highly personalized way to dose chemotherapy for advanced gastrointestinal cancers.
Redefining What’s Possible in Brain Cancer Care
Neurosurgeon Linton Evans, MD, blends compassion and cutting-edge technologies to give patients with brain tumors more time and a better quality of life.
Dartmouth Cancer Center Renews NCI Comprehensive Cancer Center Designation
Dartmouth Cancer Center enters its second half-century of continuous funding by the NCI as a designated Comprehensive Cancer Center.
Copper Trial for Triple-Negative Breast Cancer Officially Opens to Patients
In this Q&A, Linda T. Vahdat, MD, explains how cancer cells are master manipulators in the body and a promising way to stop them that she is studying in a new clinical trial.
Making Sense of Clinical Trials: A Video Q&A with Dr. Linda Vahdat
Breast oncologist and clinical researcher Linda Vahdat, MD, answers common questions about the importance of clinical trials.
A New Trial for “Triple Negative”
A promising multi-site clinical trial that has just opened at lead site Dartmouth Cancer Center looks to bring an innovative treatment strategy to one of the most challenging forms of breast cancer.